The Bantam Pharmaceutical team is led and guided by a strong experienced team and advisory board with a proven track record of success in oncology drug discovery and development.
$25M

FUNDING RAISED

Founded Q4 2015 - Novel pathway and targets, and patented technology



CLINICAL 

OPPORTUNITY

$2 billion B-cell hematological malignancy market.




DECADES

COMBINED EXPERIENCE

Prominent industry and academic leaders in oncology drug development and leadership roles.

LEADERS

ONCOLOGY

Deep experience in oncology drug discovery and development with more than a dozen products developed and approved.

Founding CEO

MICHAEL LUTHER, PhD, MBA

FOUNDING CEO, BOARD ADVISOR
Former VP drug discovery for both GSK and Merck. At GSK and Merck, Michael led teams that progressed new medicines from the bench through to the clinic.
Read More

Scientific Advisory Board

Briggs Morrison, MD, PHD
Chair of SAB
Managing Partner MPM Capitol
CEO Syndax, Inc.
Mike Patane, PhD
Former CEO, Mitobridge (Astellas)
Mark Manfredi, PhD
CEO, Ikena Therapeutics
EIR Atlas Venture
Joshua Rabinowitz, MD, PhD
Professor, Princeton University
Adrian Schwarzer, MD, PhD
Hematology/Oncology
Hannover Medical School
MICHAEL LUTHER, PHD, MBA

Board of Managers

Michael Stocum

President, CEO
Bantam Pharmaceutical



Victor Keen

OF COUNSEL AT DUANE MORRIS, LLP
CO-CHAIR CARETEC GROUP, INC (OTC)
FORMER BOARD MEMBER RESEARCH FRONTIERS, INC (NASD)

Lionel Goldfrank III

PRINCIPAL IN SEVERAL PRIVATE INVESTMENT COMPANIES
FOUNDER OF AMERICAN & OVERSEAS ASSET SERVICES CORPORATION
FORMERLY WITH GOLDMAN SACHS

W. James Tozer, Jr.

Co-owner and Founder Vectra Management Group
Former Senior Executive Citicorp and President of Prudential Securities
Founding Investor in LendingTree, Vectra Bank Colorado,
and Draper Bank
Bio-Tech Venture Investor in GangaGen, Iveena, PenBlade
and PhotoPharmics
We are an early mover in the field of mitochondrial homeostasis, using our pioneering science and unrivaled expertise in mitochondrial cellular biology to revolutionize oncology
We are seeking partners and additional investors to accelerate our clinical research and help bring novel cancer therapies closer to patients in need
Find Out More
Bantam is seeking partners and investors to drive rapid clinical development of our first-in-class molecule from First in Humans trials to clinical Proof of Concept.
CONTACT US
info@bantampharma.com
Top linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram